Angelique Boyer

1.2k total citations
21 papers, 987 citations indexed

About

Angelique Boyer is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Angelique Boyer has authored 21 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Hematology. Recurrent topics in Angelique Boyer's work include Multiple Myeloma Research and Treatments (9 papers), Peptidase Inhibition and Analysis (6 papers) and Congenital heart defects research (6 papers). Angelique Boyer is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Peptidase Inhibition and Analysis (6 papers) and Congenital heart defects research (6 papers). Angelique Boyer collaborates with scholars based in United States, Germany and United Kingdom. Angelique Boyer's co-authors include Raymond B. Runyan, Joey V. Barnett, Christopher B. Brown, Daniel L. Weeks, Éric Vincent, A.G. Evdokimov, Namal C. Warshakoon, Matthew Pokross, Shengde Wu and Richard M. Kawamoto and has published in prestigious journals such as Science, Blood and Developmental Biology.

In The Last Decade

Angelique Boyer

21 papers receiving 971 citations

Peers

Angelique Boyer
Nam-Gyun Kim South Korea
Cinzia Puppin Italy
HoangDinh Huynh United States
Reinhard Kelsch Germany
Paola Martinelli Italy
Roelof Koster Netherlands
Irma M. Sáinz United States
Laura M. Rosenberg United States
Florencia Cidre‐Aranaz Germany
Catherine J. Haskell United States
Nam-Gyun Kim South Korea
Angelique Boyer
Citations per year, relative to Angelique Boyer Angelique Boyer (= 1×) peers Nam-Gyun Kim

Countries citing papers authored by Angelique Boyer

Since Specialization
Citations

This map shows the geographic impact of Angelique Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelique Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelique Boyer more than expected).

Fields of papers citing papers by Angelique Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelique Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelique Boyer. The network helps show where Angelique Boyer may publish in the future.

Co-authorship network of co-authors of Angelique Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Angelique Boyer. A scholar is included among the top collaborators of Angelique Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelique Boyer. Angelique Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Or, Omer, et al.. (2021). Prediction of Long Bone Fractures in Multiple Myeloma Patients in an Advanced Imaging World.. PubMed. 23(8). 501–505. 1 indexed citations
2.
Forsberg, Peter A., Adriana Rossi, Angelique Boyer, et al.. (2021). Carfilzomib and dexamethasone induction with lenalidomide, clarithromycin and dexamethasone consolidation and lenalidomide maintenance for newly diagnosed multiple myeloma. American Journal of Hematology. 96(12). 1554–1562. 1 indexed citations
3.
Forsberg, Peter A., Adriana Rossi, Angelique Boyer, et al.. (2019). Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. American Journal of Hematology. 94(5). 539–545. 5 indexed citations
4.
Mark, Tomer M., Peter A. Forsberg, Adriana Rossi, et al.. (2019). Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma. Blood Advances. 3(4). 603–611. 9 indexed citations
5.
6.
Rossi, Adriana, Angelique Boyer, David Jayabalan, et al.. (2014). Effect of Renal and Hepatic Function on Pomalidomide Dose in Patients with Relapsed/Refractory Multiple Myeloma. Blood. 124(21). 4754–4754. 6 indexed citations
7.
Mark, Tomer M., John N. Allan, Angelique Boyer, et al.. (2013). Sequence Impact Of Pomalidomide and Carfilzomib On Treatment Response In Relapsed Multiple Myeloma. Blood. 122(21). 1954–1954. 2 indexed citations
8.
Mark, Tomer M., Angelique Boyer, Adriana Rossi, et al.. (2012). ClaPD (Clarithromycin, Pomalidomide, Dexamethasone) Therapy in Relapsed or Refractory Multiple Myeloma. Blood. 120(21). 77–77. 14 indexed citations
9.
Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5517–5522. 49 indexed citations
10.
Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5598–5601. 52 indexed citations
11.
Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Design and synthesis of a series of novel pyrazolopyridines as HIF 1-α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5687–5690. 68 indexed citations
12.
Warshakoon, Namal C., Shengde Wu, Angelique Boyer, et al.. (2006). Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5616–5620. 29 indexed citations
13.
Boyer, Angelique & Raymond B. Runyan. (2001). TGFβ Type III and TGFβ Type II receptors have distinct activities during epithelial–mesenchymal cell transformation in the embryonic heart. Developmental Dynamics. 221(4). 454–459. 39 indexed citations
14.
Boyer, Angelique. (2000). Trichloroethylene Inhibits Development of Embryonic Heart Valve Precursors in Vitro. Toxicological Sciences. 53(1). 109–117. 45 indexed citations
15.
16.
Runyan, Raymond B., Christopher C. Wendler, Laura Romanó, et al.. (1999). Utilization of Antisense Oligodeoxynucleotides with Embryonic Tissues in Culture. Methods. 18(3). 316–321. 9 indexed citations
17.
Boyer, Angelique, et al.. (1999). TGFβ2 and TGFβ3 Have Separate and Sequential Activities during Epithelial–Mesenchymal Cell Transformation in the Embryonic Heart. Developmental Biology. 208(2). 530–545. 171 indexed citations
18.
Brown, Christopher B., Angelique Boyer, Raymond B. Runyan, & Joey V. Barnett. (1999). Requirement of Type III TGF-β Receptor for Endocardial Cell Transformation in the Heart. Science. 283(5410). 2080–2082. 314 indexed citations
19.
Boyer, Angelique & Richard B. Hallick. (1998). Purification and characterization of a soluble DNA-dependent chloroplast RNA polymerase from Pisum sativum. Plant Science. 137(1). 13–32. 6 indexed citations
20.
Brown, Christopher B., Angelique Boyer, Raymond B. Runyan, & Joey V. Barnett. (1996). Antibodies to the Type II TGFβ Receptor Block Cell Activation and Migration during Atrioventricular Cushion Transformation in the Heart. Developmental Biology. 174(2). 248–257. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nam-Gyun Kim Breakdown of academic impact, for papers by Cinzia Puppin Breakdown of academic impact, for papers by HoangDinh Huynh Breakdown of academic impact, for papers by Reinhard Kelsch Breakdown of academic impact, for papers by Paola Martinelli Breakdown of academic impact, for papers by Roelof Koster Breakdown of academic impact, for papers by Irma M. Sáinz Breakdown of academic impact, for papers by Laura M. Rosenberg Breakdown of academic impact, for papers by Florencia Cidre‐Aranaz Breakdown of academic impact, for papers by Catherine J. Haskell
Rankless by CCL
2026